219 related articles for article (PubMed ID: 30684886)
1. EGFL7 regulates sprouting angiogenesis and endothelial integrity in a human blood vessel model.
Usuba R; Pauty J; Soncin F; Matsunaga YT
Biomaterials; 2019 Mar; 197():305-316. PubMed ID: 30684886
[TBL] [Abstract][Full Text] [Related]
2. EGFL7 Mediates BMP9-Induced Sprouting Angiogenesis of Endothelial Cells Derived from Human Embryonic Stem Cells.
Richter A; Alexdottir MS; Magnus SH; Richter TR; Morikawa M; Zwijsen A; Valdimarsdottir G
Stem Cell Reports; 2019 Jun; 12(6):1250-1259. PubMed ID: 31155507
[TBL] [Abstract][Full Text] [Related]
3. microRNA-126 inhibits tube formation of HUVECs by interacting with EGFL7 and down-regulating PI3K/AKT signaling pathway.
Li Q; Cheng K; Wang AY; Xu QG; Fu ZF; He SY; Xu PX
Biomed Pharmacother; 2019 Aug; 116():109007. PubMed ID: 31170663
[TBL] [Abstract][Full Text] [Related]
4. EGF-like-domain-7 is required for VEGF-induced Akt/ERK activation and vascular tube formation in an ex vivo angiogenesis assay.
Takeuchi K; Yanai R; Kumase F; Morizane Y; Suzuki J; Kayama M; Brodowska K; Nakazawa M; Miller JW; Connor KM; Vavvas DG
PLoS One; 2014; 9(3):e91849. PubMed ID: 24647208
[TBL] [Abstract][Full Text] [Related]
5. EGF repeats of epidermal growth factor‑like domain 7 promote endothelial cell activation and tumor escape from the immune system.
Pinte S; Delfortrie S; Havet C; Villain G; Mattot V; Soncin F
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34738625
[TBL] [Abstract][Full Text] [Related]
6. A Vascular Endothelial Growth Factor-Dependent Sprouting Angiogenesis Assay Based on an In Vitro Human Blood Vessel Model for the Study of Anti-Angiogenic Drugs.
Pauty J; Usuba R; Cheng IG; Hespel L; Takahashi H; Kato K; Kobayashi M; Nakajima H; Lee E; Yger F; Soncin F; Matsunaga YT
EBioMedicine; 2018 Jan; 27():225-236. PubMed ID: 29289530
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of EGFL7 regulating neovascularization in diabetic retinopathy through the PI3K/AKT/VEGFA pathway.
Xian Y; Wang X; Yu Y; Chen X
Life Sci; 2024 Mar; 340():122483. PubMed ID: 38307238
[TBL] [Abstract][Full Text] [Related]
8. Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts.
Liakouli V; Cipriani P; Di Benedetto P; Panzera N; Ruscitti P; Pantano I; Berardicurti O; Carubbi F; Esteves F; Mavria G; Del Galdo F; Giacomelli R
Sci Rep; 2019 Mar; 9(1):4589. PubMed ID: 30872612
[TBL] [Abstract][Full Text] [Related]
9. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
10. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic down-regulation of microRNA-126 in scleroderma endothelial cells is associated with impaired responses to VEGF and defective angiogenesis.
Wang Y; Sun J; Kahaleh B
J Cell Mol Med; 2021 Jul; 25(14):7078-7088. PubMed ID: 34137496
[TBL] [Abstract][Full Text] [Related]
12. LncEGFL7OS regulates human angiogenesis by interacting with MAX at the EGFL7/miR-126 locus.
Zhou Q; Yu B; Anderson C; Huang ZP; Hanus J; Zhang W; Han Y; Bhattacharjee PS; Srinivasan S; Zhang K; Wang DZ; Wang S
Elife; 2019 Feb; 8():. PubMed ID: 30741632
[TBL] [Abstract][Full Text] [Related]
13. Impaired angiogenesis and altered Notch signaling in mice overexpressing endothelial Egfl7.
Nichol D; Shawber C; Fitch MJ; Bambino K; Sharma A; Kitajewski J; Stuhlmann H
Blood; 2010 Dec; 116(26):6133-43. PubMed ID: 20947685
[TBL] [Abstract][Full Text] [Related]
14. CMTM4 regulates angiogenesis by promoting cell surface recycling of VE-cadherin to endothelial adherens junctions.
Chrifi I; Louzao-Martinez L; Brandt MM; van Dijk CGM; Bürgisser PE; Zhu C; Kros JM; Verhaar MC; Duncker DJ; Cheng C
Angiogenesis; 2019 Feb; 22(1):75-93. PubMed ID: 30097810
[TBL] [Abstract][Full Text] [Related]
15. EGFL7 is expressed in bone microenvironment and promotes angiogenesis via ERK, STAT3, and integrin signaling cascades.
Chim SM; Kuek V; Chow ST; Lim BS; Tickner J; Zhao J; Chung R; Su YW; Zhang G; Erber W; Xian CJ; Rosen V; Xu J
J Cell Physiol; 2015 Jan; 230(1):82-94. PubMed ID: 24909139
[TBL] [Abstract][Full Text] [Related]
16. VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network.
Huang C; Yuan X; Wan Y; Liu F; Chen X; Zhan X; Li X
Int J Clin Exp Pathol; 2014; 7(3):1022-31. PubMed ID: 24696719
[TBL] [Abstract][Full Text] [Related]
17. VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.
Huang C; Yuan X; Li Z; Tian Z; Zhan X; Zhang J; Li X
Int J Clin Exp Pathol; 2014; 7(3):1077-84. PubMed ID: 24696724
[TBL] [Abstract][Full Text] [Related]
18. Role of EGFL7 in human cancers: A review.
de Oliveira C; Gonçalves PG; Bidinotto LT
J Cell Physiol; 2023 Aug; 238(8):1756-1767. PubMed ID: 37490307
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor-like domain 7 is a marker of the endothelial lineage and active angiogenesis.
Bambino K; Lacko LA; Hajjar KA; Stuhlmann H
Genesis; 2014 Jul; 52(7):657-70. PubMed ID: 24740971
[TBL] [Abstract][Full Text] [Related]
20. Treatment of pregnancies complicated by intrauterine growth restriction with nitric oxide donors increases placental expression of Epidermal Growth Factor-Like Domain 7 and improves fetal growth: A pilot study.
Massimiani M; Tiralongo GM; Salvi S; Fruci S; Lacconi V; La Civita F; Mancini M; Stuhlmann H; Valensise H; Campagnolo L
Transl Res; 2021 Feb; 228():28-41. PubMed ID: 32784003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]